Privacy Commissioner of Canada ArriveCAN App Investigation Report

The Privacy Commissioner of Canada has tabled a special report on the ArriveCAN app investigation. While no contraventions of the Privacy Act were found, the report outlines steps the Canada Border Services Agency must take to strengthen privacy and security in its contracting framework.

ASC Investor Alert: BG Wealth Sharing Suspected Investment Scheme

The Alberta Securities Commission (ASC) has issued an investor alert warning the public about BG Wealth Sharing, a suspected investment scheme promoted via social media and messaging apps. The scheme, linked to DSJ Exchange, claims to use AI for guaranteed returns and is not registered in Alberta.

Court Dismisses Ronald Aitkens' Appeal of Fraud Conviction

The Alberta Securities Commission (ASC) announced that the Court of King's Bench dismissed Ronald Aitkens' appeal of his 2024 conviction and sentence for fraud and making false or misleading statements. The appeal related to securities distributed through an offering memorandum for Legacy Communities Inc.

Securities Regulators Amend Benchmark Assurance Report Requirements

Canadian securities regulators have adopted final amendments to Multilateral Instrument 25-102, strengthening assurance report requirements for designated benchmarks. These changes clarify the scope, timing, and level of assurance for reports submitted by independent public accountants, effective May 5, 2026.

ASC Alleges Securities Law Breaches by Daniel Astete and 2307755 Alberta Ltd

The Alberta Securities Commission (ASC) has issued a Notice of Hearing alleging that Daniel Rodolfo Astete and 2307755 Alberta Ltd. breached Alberta securities laws by engaging in illegal distributions of securities. The companies allegedly raised approximately $500,000 through a crowdfunding platform without filing a prospectus, and improperly paid $21,000 to Astete from the funds raised.

CSA Disarms Over 7,500 Fraudulent Investment Websites

Canadian securities regulators have announced the successful deactivation of over 7,500 fraudulent investment and crypto scam websites between June 2025 and February 2026. This initiative, highlighted during Fraud Prevention Month, aims to protect investors from online scams.

Health Canada Implements ICH Pharmaceutical Guidelines

Health Canada is implementing new International Council for Harmonisation (ICH) guidelines for pharmaceuticals, including M13A and Q12/Q14. These implemented ICH guidelines will take precedence over existing Health Canada guidance documents where discrepancies exist, potentially leading to amendments or withdrawals of current guidance.

ICH Consultations on Patient Preference, Extractables, and Adaptive Trials

Health Canada announced three International Council for Harmonisation (ICH) draft guidelines are open for public consultation. The consultations cover patient preference studies, extractables and leachables, and adaptive clinical trials, with comment deadlines ranging from November 2025 to April 2026.

Health Canada Implements ICH Q12 and Q14 Guidance

Health Canada has announced the implementation of International Council for Harmonisation (ICH) Q12 and Q14 guidance. The initial scope focuses on Post Approval Change Management Protocols (PACMPs) for Biologic and Radiopharmaceutical Drugs Directorate products, with further implementation details to follow.

Health Product Shortages in Canada: 2024-2025 Review

Health Canada has released its review of health product shortages for the 2024-2025 fiscal year. The report details drug and medical device shortages, including reporting requirements for manufacturers and highlights of high-impact cases. It notes a decrease in new drug shortage reports compared to the previous year.